(Q36546265)

14 August 2017

1 reference

title

Methods of evaluating immunotoxicity (English)

1 reference

14 August 2017

Jacques Descotes

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

Expert Opinion on Drug Metabolism & Toxicology

14 August 2017

published in

1 reference

14 August 2017

volume

2

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

249-259

1 reference

Immune Suppression as Related to Toxicology

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Summary of an international methods validation study, carried out in nine laboratories, on the immunological assessment of cyclosporin A in the Fischer 344 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Validation of a modified 28-day rat study to evidence effects of test compounds on the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Toxic oil syndrome: the perspective after 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Drug-induced hypersensitivity: role in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Adverse effects of immunotherapeutics involving the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Infection in organ-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Infections associated with steroid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Serious infections associated with anticytokine therapies in the rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Immunosuppressive drugs and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Autoimmune aspects of cytokine and anticytokine therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Hepatic drug metabolism and immunostimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Epidemiology of hypersensitivity drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Drug allergy diagnosis in humans: possibilities and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Allergic reactions to drugs and biologic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Gell and Coombs's classification: is it still valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Molecular aspects of drug recognition by specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Drug-induced autoimmunity: experience of the French pharmacovigilance system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Autoimmune diseases associated with drugs, chemicals and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Determination of lymphocyte subsets and cytokine levels in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Development and validation of a canine T-cell-dependent antibody response model for immunotoxicity evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

US FDA "Redbook II" immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

The accuracy of extended histopathology to detect immunotoxic chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Histopathologic approaches to detect changes indicative of immunotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Two immunotoxicity ring studies according to OECD TG 407-comparison of data on cyclosporin A and hexachlorobenzene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Validation of immune function testing during a 4-week oral toxicity study with FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

T-cell-dependent antibody response: assay development in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Application of flow cytometry to immunotoxicity testing: summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Uses and future applications of flow cytometry in immunotoxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Phagocytosis: measurement by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Theory and practice of cytokine assessment in immunotoxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Plasma cytokines: what we are measuring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Animal models in autoimmune disease in immunotoxicity assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

TNF-alpha release from human peripheral blood mononuclear cells to predict the proinflammatory activity of cytokines and growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Clinical relevance of preclinical testing for allergic side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Anaphylaxis models in the guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Assessment of the allergic potential of food protein extracts and proteins on oral application using the brown Norway rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

The local lymph node assay: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Results with OECD recommended positive control sensitizers in the maximization, Buehler and local lymph node assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Detection of systemic hypersensitivity to drugs using standard guinea pig assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Toxicity of polyoxyethylene hydrogenated castor oil 60 (HCO-60) in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Hypersensitivity reactions to Althesin infusion: measurement of complement involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Autoimmunity and toxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Autoantibodies in conventional toxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Popliteal lymph node assay: facts and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Predictive testing for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Epidemiology studies in immunotoxicity evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

Epstein–Barr virus infection: basis of malignancy and potential for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.2.249

21 January 2018

Identifiers

DOI

10.1517/17425255.2.2.249

1 reference

14 August 2017

1 reference